BAML, Ares, Montagu realise €485m partial sale

BAML Capital Partners, Ares Life Sciences and Montagu Private Equity-backed Euromedic has sold its dialysis care division in a €485m sale to Fresenius Medical Care, the world's largest dialysis services provider.

The sale comes three years after Ares and Merrill Lynch Private Equity led the secondary buyout of Euromedic from incumbent backer Warburg Pincus. Montagu became a shareholder around nine months later, in September 2008.

Euromedic is a Hungary-based, pan-European provider of medical services. Its sale of International Dialysis Centres is part of a strategy to focus on core businesses in the field of diagnostics and cancer treatment. Euromedic is the largest provider of dialysis services in Eastern Europe, treating over 8,200 patients in nine countries. Fresenius currently serves more than 210,000 patients globally and more than 17,000 patients in Eastern Europe.

Bank of America Merrill Lynch acted as financial adviser to Euromedic. Linklaters and White & Case provided legal advice.

 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• CEE
• Exits
• Montagu Private Equity